drugset
drugset / Trial / NCT05938699

Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

NCT05938699 ↗

Phase 2/3 Completed 18 enrolled Nicox Ophthalmics, Inc.
RandomizedParallel-groupTriple-blindBasic science

Summary

This is a double-masked, placebo-controlled study which will determine the action of NCX 470 ophthalmic solution, 0.1% on aqueous humor dynamic parameters in healthy volunteers or subjects with OHT.

Timeline

Start
2023-12-12
Primary completion
2025-03-17
Completion
2025-03-17

Drugs

EvaluationDrugModalityDoseRoute
Comparator NCX 470 Unknown 0.1 % Other

Indications

open-angle glaucoma